NCT03672123View on ClinicalTrials.gov

GDF-15 Levels in Risk Stratification in Acute Pulmonary Embolism

CompletedOBSERVATIONAL
Enrollment

270

Participants

Timeline

Start Date

September 17, 2018

Primary Completion Date

June 30, 2023

Study Completion Date

June 30, 2023

Conditions
Pulmonary Embolism
Trial Locations (1)

02-005

Department of Internal Medicine & Cardiology with the Centre for Management of Venous Thromboembolic Disease, Medical University of Warsaw, Warsaw

All Listed Sponsors
collaborator

National Science Center, Poland

UNKNOWN

lead

Medical University of Warsaw

OTHER

NCT03672123 - GDF-15 Levels in Risk Stratification in Acute Pulmonary Embolism | Biotech Hunter | Biotech Hunter